UBS Call 79 AZN 17.01.2025/ DE000UM5KCY3 /
26.06.2024 19:25:38 | Diff.-0,020 | Geld21:59:51 | Brief21:59:51 | Basiswert | Basispreis | Fälligkeit | Optionsart |
---|---|---|---|---|---|---|---|
0,660EUR | -2,94% | 0,650 Geld Vol: 10.000 |
0,710 Brief Vol: 10.000 |
AstraZeneca PLC | 79,00 - | 17.01.2025 | Call |
GlobeNewswire
23:00
CenterPoint Energy, Inc. to Host Webcast of Second Quarter 2024 Earnings Conference Call
GlobeNewswire
23:00
ROHM Develops a Novel VCSELED™ Infrared Light Source that Combines Features of VCSELs and LEDs
GlobeNewswire
22:53
OV Entertainment Group Acquires Brazilian Studio Kokku Games and Argentinian Studio 3OGS
GlobeNewswire
22:41
Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials La...
GlobeNewswire
22:39
NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced...
Newsfile Corp
22:36
CSE Bulletin: Expiry - VSBLTY Groupe Technologies Corp. 29JUNE2024 Warrants (VSBY.WT.A)
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite